mianserin has been researched along with Cardiovascular Diseases in 7 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mianserin is a tetracyclic compound advocated for the treatment of depressive illness and depression associated with anxiety." | 4.75 | Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| " Notably, noradrenergic and specific serotonergic antidepressant (mirtazapine) use was significantly associated with higher prevalence of heart failure (OR 3." | 3.79 | Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population. ( Acharya, S; Acharya, T; Huang, J; Tringali, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, T | 1 |
| Acharya, S | 1 |
| Tringali, S | 1 |
| Huang, J | 1 |
| de Jonge, P | 1 |
| Honig, A | 1 |
| van Melle, JP | 1 |
| Schene, AH | 1 |
| Kuyper, AM | 1 |
| Tulner, D | 1 |
| Schins, A | 1 |
| Ormel, J | 1 |
| Kopera, H | 1 |
| Burgess, CD | 1 |
| Montgomery, SA | 1 |
| Montgomery, DB | 1 |
| Wadsworth, J | 1 |
| Pinder, RM | 1 |
| Fink, M | 1 |
| Brogden, RN | 1 |
| Heel, RC | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Burrows, GD | 1 |
| Norman, TR | 1 |
| Dennerstein, L | 1 |
| Davies, BM | 1 |
3 reviews available for mianserin and Cardiovascular Diseases
| Article | Year |
|---|---|
Mianserin.
Topics: Animals; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Central Nervous System; Depressi | 1982 |
Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
Topics: Amitriptyline; Animals; Antidepressive Agents; Carbohydrate Metabolism; Cardiovascular Diseases; Dep | 1978 |
Antidepressant therapy: benefits and risks in perspective.
Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Depressive Disorder; Dibenzazepines | 1985 |
2 trials available for mianserin and Cardiovascular Diseases
| Article | Year |
|---|---|
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.
Topics: Antidepressive Agents; Cardiovascular Diseases; Cause of Death; Citalopram; Comorbidity; Depressive | 2007 |
Lack of anticholinergic and cardiovascular effects of mianserin; studies in healthy subjects and heart patients.
Topics: Amitriptyline; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Depressive Disorde | 1983 |
2 other studies available for mianserin and Cardiovascular Diseases
| Article | Year |
|---|---|
Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Cardiovascular Diseases; Cross-Sectional S | 2013 |
Cardiovascular effects of amitriptyline, mianserin and zimelidine in depressed patients.
Topics: Adult; Amitriptyline; Antidepressive Agents; Blood Pressure; Brompheniramine; Cardiovascular Disease | 1980 |